drugset / Trial / NCT01688947
Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary objective of this study is to evaluate the analgesic efficacy of 2 dose levels of V116517 versus placebo.
Timeline
- Start
- 2012-09
- Primary completion
- 2014-03
- Completion
- 2014-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Pregabalin | Small molecule | — | Oral |
| Subject | V116517 | Unknown | 30 mg | Oral |
| Subject | V116517 | Unknown | 50 mg | Oral |